Zetagen Therapeutics

BiotechnologySeries BSyracuse, USzetagen.com

Latest round

Series B

Last raised

Oct 2025

Total raised

$13M

Investors

3

About Zetagen Therapeutics

Founded in 2015 and based in New York, US, Zetagen Therapeutics, In October 2025, Zetagen Therapeutics, Inc. operates as a clinical-stage, biopharmaceutical company. In October 2025, Zetagen Therapeutics, Inc.88 million post-money. The firm develops and offers biopharmaceuticals that are designed for intra-tumoral injection in soft tissue organs like the liver, lung, and or brain to help treat metastatic cancers to bone and other organs. The firm’s products include ZetaMet Flowable™, ZetaFuse™, ZetaSet™,  ZetaDent™, and ZetaBase™, which are designed to suspend cancer, inhibit pain, and regenerate bone.

Who invested in Zetagen Therapeutics

3 investors across 2 rounds

See all investors in Zetagen Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Oct 31, 2025

    Amount

    $13M

    Investors

    Locked

  2. Series B

    Jan 21, 2025

    Amount

    $0.1M

    Investors

    Locked

Questions about Zetagen Therapeutics

Who invested in Zetagen Therapeutics?

Zetagen Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Zetagen Therapeutics raised?

Zetagen Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Zetagen Therapeutics last raise money?

Zetagen Therapeutics's most recent round on record is a Series B, in Oct 2025.

What does Zetagen Therapeutics do?

Founded in 2015 and based in New York, US, Zetagen Therapeutics, In October 2025, Zetagen Therapeutics, Inc.

Where is Zetagen Therapeutics headquartered?

Zetagen Therapeutics is headquartered in Syracuse, US.

Which VCs invest in companies like Zetagen Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Zetagen Therapeutics's stage. Their profiles are linked below.

Raising like Zetagen Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.